148 related articles for article (PubMed ID: 15564451)
21. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
[TBL] [Abstract][Full Text] [Related]
22. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
[TBL] [Abstract][Full Text] [Related]
23. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
Marsac D; Puaux AL; Rivière Y; Michel ML
Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
[TBL] [Abstract][Full Text] [Related]
24. Ancestral and consensus envelope immunogens for HIV-1 subtype C.
Kothe DL; Li Y; Decker JM; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Weng Z; Weaver EA; Gao F; Haynes BF; Shaw GM; Korber BT; Hahn BH
Virology; 2006 Sep; 352(2):438-49. PubMed ID: 16780913
[TBL] [Abstract][Full Text] [Related]
25. Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity.
Bhakta SJ; Shang L; Prince JL; Claiborne DT; Hunter E
Retrovirology; 2011 May; 8():37. PubMed ID: 21569545
[TBL] [Abstract][Full Text] [Related]
26. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
27. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
28. Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.
Ilinskaya A; Heidecker G; Derse D
J Virol; 2010 Jul; 84(14):6995-7004. PubMed ID: 20463077
[TBL] [Abstract][Full Text] [Related]
29. Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.
Abada P; Noble B; Cannon PM
J Virol; 2005 Mar; 79(6):3627-38. PubMed ID: 15731257
[TBL] [Abstract][Full Text] [Related]
30. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
Bower JF; Li Y; Wyatt R; Ross TM
Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
[TBL] [Abstract][Full Text] [Related]
32. Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.
Yu JS; Peacock JW; Jacobs WR; Frothingham R; Letvin NL; Liao HX; Haynes BF
Clin Vaccine Immunol; 2007 Jul; 14(7):886-93. PubMed ID: 17507541
[TBL] [Abstract][Full Text] [Related]
33. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
34. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells.
Radaelli A; Bonduelle O; Beggio P; Mahe B; Pozzi E; Elli V; Paganini M; Zanotto C; De Giuli Morghen C; Combadière B
Vaccine; 2007 Mar; 25(11):2128-38. PubMed ID: 17241705
[TBL] [Abstract][Full Text] [Related]
35. The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis.
Bowers K; Pelchen-Matthews A; Höning S; Vance PJ; Creary L; Haggarty BS; Romano J; Ballensiefen W; Hoxie JA; Marsh M
Traffic; 2000 Aug; 1(8):661-74. PubMed ID: 11208154
[TBL] [Abstract][Full Text] [Related]
36. Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells.
Zaides V; Yagello M; Veselovskaya T; Schmitt D; Rykova L; Fenouillet E; Gluckman JC
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2963-75. PubMed ID: 7964606
[TBL] [Abstract][Full Text] [Related]
37. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.
Lu S; Santoro JC; Fuller DH; Haynes JR; Robinson HL
Virology; 1995 May; 209(1):147-54. PubMed ID: 7747464
[TBL] [Abstract][Full Text] [Related]
38. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
Fuller DH; Haynes JR
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
[TBL] [Abstract][Full Text] [Related]
39. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL
Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282
[TBL] [Abstract][Full Text] [Related]
40. A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein.
Byland R; Vance PJ; Hoxie JA; Marsh M
Mol Biol Cell; 2007 Feb; 18(2):414-25. PubMed ID: 17108326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
